Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years-Reference-Cited by-同舟云学术

Methotrexate-induced pancytopenia: serious and under-reported? Our experience of 25 cases in 5 years

Published:2005-05-18 Issue:8 Volume:44 Page:1051-1055
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Lim A. Y. N.,Gaffney K.,Scott D. G. I.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/44/8/1051/9447922/keh685.pdf

Reference28 articles.

1. Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum1996;39:1951–60.

2. Weinblatt ME. Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumatol1985;(Suppl 12):35–9.

3. Grove ML, Hassell AB, Hay EM, Shadforth MF. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. Q J Med2001;94:309–19.

4. Kremer J, Galivan J, Streckfuss A, Kamen B. Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum1986;29:832–5.

5. Leeb B, Witzmann G, Ogris E et al. Folic acid and cyanocobalamin levels in serum and erythrocytes during low dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients. Clin Exp Rheumatol1995;13:459–63.

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methotrexate-induced Severe Pancytopenia in a Patient with Rheumatoid Arthritis: A Case Report and Review of Literature;Current Drug Safety;2024-05

2. Bewertung von Wechselwirkungen und Dosierungsempfehlungen von synthetischen DMARDs – Evidenz- und konsensbasierte Empfehlungen auf Basis einer systematischen Literatursuche;Zeitschrift für Rheumatologie;2023-10-13

3. Japan College of Rheumatology guidance for the use of methotrexate in patients with rheumatoid arthritis: Secondary publication;Modern Rheumatology;2023-10-11

4. Comparison of two doses of leucovorin in severe low-dose methotrexate toxicity – a randomized controlled trial;Arthritis Research & Therapy;2023-05-19

5. Bewertung von Wechselwirkungen und Dosierungsempfehlungen von synthetischen DMARDs – Evidenz- und konsensbasierte Empfehlungen auf Basis einer systematischen Literatursuche;Zeitschrift für Rheumatologie;2023-01-12